1-(2-Aminophenyl)-2,2,2-trifluoroethan-1-ol, 95+%, 500mg

2-Bromo-4-methoxy-5-methylpyridine, 97%, 1g

2,3-Naphthalenedicarboxylic Anhydride>95.0%(GC)(T)25g

Bismuth oxide 99.999% 50 g

3,5-Dichloro-2-fluorotoluene, 95%, 500mg

3,4-Difluorobenzenesulfonyl chloride, 97.0%, 25g

5-Ethyl-2-thiophenecarboxaldehyde, 98.0%, 5g

Microliter syringe GASTIGHT® series 1700 Point type 3, 500 µl, 1750 RNR, 1 piece

3-FLUORO-5-METHOXYPHENYLBORONIC ACID PINACOL ESTER, 95.0%, 5g

EPIRUBICIN HYDROCHLORIDE, 95%, 10mg

2-(9-(Pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl)acetonitrile, 97%, 250mg

(4-(N-Ethylsulfamoyl)-2-methylphenyl)boronic acid, 95.0%, 250mg

5-Chlorothieno[3,2-b]pyridine, 95.0%, 1g